50
Last reporting period 30 Jun, 2023
Updated —
Last price
—
Market cap $B
0.214
Exchange
XHKG - Hong Kong Exchange
2.4
Last period Current ratio
121%
Current ratio has increased in 5 years
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also Lansen Pharmaceutical
Company Analysis
503.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
503.HK financial analysis by Eyestock methodology
Valuation
503.HK valuation using historical relative method
Statements
503.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
503.HK dividend yield and annual dividend
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
Lansen Pharmaceutical`s Current ratio for the last twelve months ended 2023-06-30 is 2.4
